Results 101 to 110 of about 5,666,574 (155)

Teprotumumab Effect on Proptosis, Diplopia and Quality of Life in Active Thyroid Eye Disease (TED) (Video)

, 2020
Active thyroid eye disease (TED), a progressive, autoimmune condition, produces retro-orbital inflammation/tissue expansion. Patients present with ocular pain, redness, and swelling.
Jade Schiffman; Rosa Tang; George Kahaly; Terry Smith; Saba Sile; Elizabeth Thompson; Thomas Vescio; Jeffrey Sherman; Raymond Douglas
core  

Associations among thyroid function, white matter microstructure, and emotional disturbances in thyroid eye disease

BMC Medical Imaging
Objectives To characterize white matter microstructural abnormalities in thyroid eye disease (TED) using tract-based spatial statistics (TBSS) of diffusion tensor imaging (DTI) and diffusion kurtosis imaging (DKI), and to explore their associations with ...
Zimin Zhang, Haiyang Zhang, Xuefei Song, Yang Song, Huifang Zhou, Ling Zhu, Xiaofeng Tao, Mengda Jiang   +7 more
doaj   +1 more source

Thyroid Eye Disease in the Elderly

, 2010
The time of onset of thyroid eye disease (TED), an autoimmune orbital disorder, is known to follow a bimodal peak: 40-44 years and 60-64 years in women, as well as 45-49 and 65-69 years in ...
Hana Leiba; Taiba Zornitzki; Ruth Huna-Baron; Beatrix Hadas; Klara Landau
core  

Thyroid Eye Disease (Ted) Management: A Case Report

Acta Scientific Ophthalmology, 2020
openaire   +1 more source

Thyroid Eye Disease in Young Patients Compared with Older

, 2010
To compare clinical features of thyroid eye disease (TED) patients younger than 40 years of age with older ...
Ruth Huna-Baron; Gaby Katz; Hana Leiba; Biatrix Hadas; Guy J. Ben Simon
core  

Teprotumumab Effect on Proptosis, Diplopia and Quality of Life in Active Thyroid Eye Disease (TED) (Slides)

, 2020
Active thyroid eye disease (TED), a progressive, autoimmune condition, produces retro-orbital inflammation/tissue expansion. Patients present with ocular pain, redness, and swelling.
Jade Schiffman; Rosa Tang; George Kahaly; Terry Smith; Saba Sile; Elizabeth Thompson; Thomas Vescio; Jeffrey Sherman; Raymond Douglas
core  

Evaluation of clinical and ocular surface changes in thyroid eye disease: impact of treatment and risk factors

Therapeutic Advances in Ophthalmology
Background: Thyroid eye disease (TED) is an autoimmune inflammatory condition affecting the orbit and ocular surface, often leading to proptosis, diplopia, and evaporative dry eye.
Şule Barman Kakil, Neşe Arslan
doaj   +1 more source

Light Discomfort Thresholds in Patients with Moderate-to-Severe Active versus Mild Non-Active Thyroid Eye Disease

Clinical Ophthalmology
Filippo Lixi,1,2 Silvia Corrias,3 Giulia Coco,4 Roberta Lai,1 Claudia Corda,1 Alberto Cuccu,1 Livio Vitiello,5 Mario Troisi,6 Chiara Mura,3 Francesco Boi,3 Giulia Lanzolla,3,* Giuseppe Giannaccare1,* 1Eye Clinic, Department of Surgical ...
Lixi F, Corrias S, Coco G, Lai R, Corda C, Cuccu A, Vitiello L, Troisi M, Mura C, Boi F, Lanzolla G, Giannaccare G   +11 more
doaj  

TR12 Diagnostic challenges in thyroid eye disease

Background/Introduction Thyroid eye disease (TED) is the most common extrathyroidal manifestation of thyroid disease. Although diagnosis is usually based on clinical presentation, thyroid function, autoantibodies, and orbital imaging,
N Joksimović, B Nedeljković Beleslin, M Miletić, B Marković, M Žarković, M Stojković, J Babić, T Janić   +7 more
core   +1 more source

The psychosocial and clinical outcomes of surgery for Thyroid Eye Disease (TED)

This study aimed to investigate whether quality of life in patients with thyroid eye disease (TED) improves as a result of having orbital decompression surgery and whether any demographic, clinical or psychosocial factors can predict which patients might benefit from this surgery.\ud \ud One hundred and twenty three adults with TED were recruited from ...
openaire   +1 more source